Search Results - "Warrellow, Graham"
-
1
Racemic and chiral sulfoxides as potential prodrugs of the COX-2 inhibitors Vioxx ® and Arcoxia
Published in Bioorganic & medicinal chemistry letters (15-06-2006)“…The enantiomeric synthesis and profiling of sulfoxide-based rofecoxib and etoricoxib (Merck) prodrugs are reported. The preparation of the sulfoxide analogues…”
Get full text
Journal Article -
2
Squaric acid derivatives as VLA-4 integrin antagonists
Published in Bioorganic & medicinal chemistry letters (08-04-2002)“…SAR studies aimed at improving the rate of clearance by the incorporation of a 3,4-diamino-3-cyclobutene-1,2-dione group as an amino acid isostere in a series…”
Get full text
Journal Article -
3
Discovery and evaluation of N-(triazin-1,3,5-yl) phenylalanine derivatives as VLA-4 integrin antagonists
Published in Bioorganic & medicinal chemistry letters (17-06-2002)“…SAR studies aimed at improving the rate of clearance of a series of VLA-4 integrin antagonists by the introduction of a 1,3,5-triazine as an amide isostere are…”
Get full text
Journal Article -
4
PDE 4 inhibitors: the use of molecular cloning in the design and development of novel drugs
Published in Drug discovery today (01-03-1997)“…Phosphodiesterase 4 (PDE 4) enzymes are the principal phosphodiesterases responsible for the hydrolysis of cAMP in pro-inflammatory leukocytes. The functional…”
Get full text
Journal Article -
5
Dehydrophenylalanine derivatives as VLA-4 integrin antagonists
Published in Bioorganic & medicinal chemistry letters (10-03-2003)“…We describe a series of dehydrophenylalanine derivatives where the Z isomers are potent VLA-4 antagonists but are subject to rapid biliary clearance and the E…”
Get full text
Journal Article -
6
N-(Pyrimidin-4-yl) and N-(Pyridin-2-yl) phenylalanine derivatives as VLA-4 integrin antagonists
Published in Bioorganic & medicinal chemistry letters (17-06-2002)“…The SAR studies to optimise both potency and rate of clearance in the rat for a series of pyrimidine and pyridine based VLA-4 antagonists are described. A…”
Get full text
Journal Article -
7
Interview with Graham Warrellow by Isaac Bruce
Published in Future medicinal chemistry (01-06-2012)“…Following his academic studies at the University of Surrey (UK), Graham Warrellow entered the pharmaceutical industry to pursue a career at the forefront of…”
Get more information
Journal Article -
8
Discovery and evaluation of potent, cysteine-based α4β1 integrin antagonists
Published in Bioorganic & medicinal chemistry letters (01-05-2000)Get full text
Journal Article -
9
Investigation of the in Vitro Metabolism Profile of a Phosphodiesterase-IV Inhibitor, CDP-840: Leading to Structural Optimization
Published in Drug metabolism and disposition (01-03-2001)“…CDP-840 is a selective and potent phosphodiesterase type IV inhibitor, whose in vitro metabolism profile was first investigated using liver microsomes from…”
Get full text
Journal Article -
10
Racemic and chiral sulfoxides as potential prodrugs of 4-pyrone COX-2 inhibitors
Published in Bioorganic & medicinal chemistry letters (01-07-2006)“…The enantiomeric synthesis and profiling of sulfoxide-based prodrugs of potent COX-2 inhibitors discovered at Almirall are reported. The preparation of the…”
Get full text
Journal Article -
11
Discovery and Characterization of 4‘-(2-Furyl)-N-pyridin-3-yl-4,5‘-bipyrimidin-2‘-amine (LAS38096), a Potent, Selective, and Efficacious A2B Adenosine Receptor Antagonist
Published in Journal of medicinal chemistry (31-05-2007)“…A novel series of N-heteroaryl 4‘-(2-furyl)-4,5‘-bipyrimidin-2‘-amines has been identified as potent and selective A2B adenosine receptor antagonists. In…”
Get full text
Journal Article -
12
Synthesis and .alpha.2-adrenoceptor antagonist activity of some disulfonamidobenzoquinolizines
Published in Journal of medicinal chemistry (01-01-1989)Get full text
Journal Article -
13
Racemic and chiral sulfoxides as potential prodrugs of the COX-2 inhibitors Vioxx super([registered]) and Arcoxia super([registered])
Published in Bioorganic & medicinal chemistry letters (01-06-2006)“…The preparation of the sulfoxide analogues 2 and 4, and their enantiomeric pure forms is discussed as well as their potential to act as prodrugs to the potent…”
Get full text
Journal Article -
14
Synthesis and Structure−Activity Relationships of Novel Histamine H 1 Antagonists: Indolylpiperidinyl Benzoic Acid Derivatives
Published in Journal of medicinal chemistry (02-12-2004)Get full text
Journal Article -
15
Synthesis and structure-activity relationships of piperidinylpyrrolopyridine derivatives as potent and selective H1 antagonists
Published in Bioorganic & medicinal chemistry letters (15-02-2005)“…The synthesis and structure-activity relationships of piperidinylpyrrolopyridines as potent and selective H(1) antagonists are discussed. It was found that the…”
Get full text
Journal Article -
16
-
17
Synthesis and structure–activity relationships of piperidinylpyrrolopyridine derivatives as potent and selective H 1 antagonists
Published in Bioorganic & medicinal chemistry letters (15-02-2005)“…[Display omitted] The synthesis and structure–activity relationships of piperidinylpyrrolopyridines as potent and selective H 1 antagonists are discussed. It…”
Get full text
Journal Article -
18
Discovery and evaluation of potent, tyrosine-based α4β1 integrin antagonists
Published in Bioorganic & medicinal chemistry letters (01-05-2000)Get full text
Journal Article -
19
Synthesis and Structure−Activity Relationships of Novel Histamine H1 Antagonists: Indolylpiperidinyl Benzoic Acid Derivatives
Published in Journal of medicinal chemistry (02-12-2004)“…A series of indolylpiperidinyl derivatives were prepared and evaluated for their activity as histamine H1 antagonists. Structure−activity relationship studies…”
Get full text
Journal Article -
20